Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruutu

Showing results (471-480 of 483) with videos related to

Pageof 49
Sort By:
European Journal of Haematology|May 31, 2022
Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia GroupAarne Kolonen, Marjatta Sinisalo, Heini Huhtala, et al.
Bone Marrow Transplantation|April 24, 2023
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)Mohamad Mohty, Florent Malard, Ahmed S Alaskar, et al.
The Lancet. Haematology|February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Tapani Ruutu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 29, 2010
Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in miceTarl W Prow, Xianfeng Chen, Natalie A Prow, et al.
European Urology|August 8, 2009
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)Monique J Roobol, Melissa Kerkhof, Fritz H Schröder, et al.
Bone Marrow Transplantation|April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert groupMarion Larue, Florent Malard, Ahmed S Alaskar, et al.
Bone Marrow Transplantation|August 12, 2023
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party studyTapani Ruutu, Christophe Peczynski, Mohamed Houhou, et al.
Bone Marrow Transplantation|March 24, 2015
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)M Mohty, F Malard, M Abecassis, et al.
The New England Journal of Medicine|January 7, 2016
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host DiseaseNicolaus Kröger, Carlos Solano, Christine Wolschke, et al.
The Lancet. Haematology|February 3, 2019
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised studyFrancesca Bonifazi, Carlos Solano, Christine Wolschke, et al.
Pageof 49

Showing results (471-480 of 483) with videos related to

Sort By:
Pageof 49
European Journal of Haematology|May 31, 2022
Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia GroupAarne Kolonen, Marjatta Sinisalo, Heini Huhtala, et al.
Bone Marrow Transplantation|April 24, 2023
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)Mohamad Mohty, Florent Malard, Ahmed S Alaskar, et al.
The Lancet. Haematology|February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Tapani Ruutu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 29, 2010
Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in miceTarl W Prow, Xianfeng Chen, Natalie A Prow, et al.
European Urology|August 8, 2009
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)Monique J Roobol, Melissa Kerkhof, Fritz H Schröder, et al.
Bone Marrow Transplantation|April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert groupMarion Larue, Florent Malard, Ahmed S Alaskar, et al.
Bone Marrow Transplantation|August 12, 2023
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party studyTapani Ruutu, Christophe Peczynski, Mohamed Houhou, et al.
Bone Marrow Transplantation|March 24, 2015
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)M Mohty, F Malard, M Abecassis, et al.
The New England Journal of Medicine|January 7, 2016
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host DiseaseNicolaus Kröger, Carlos Solano, Christine Wolschke, et al.
The Lancet. Haematology|February 3, 2019
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised studyFrancesca Bonifazi, Carlos Solano, Christine Wolschke, et al.
Pageof 49